EUVIMEDEUVIMED entdecken
Crossref

Dose estimation in patients from different protocols of 18F-FDG PET/CT studies and analysis of optimization strategies

Pooja Dwivedi iD, Ashish Kumar Jha, Sneha Mithun, Viraj Sawant, Vishal Vajarkar, Manoj Chauhan, Sayak Choudhury, Venkatesh Rangarajan

Radiation Protection Dosimetry · 2024

DOI: 10.1093/rpd/ncae179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Protection Dosimetry, 2024. Verfasst von Pooja Dwivedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, Advanced Centre for Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Radiation Dosage, Radiopharmaceuticals. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the dose in different protocols of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (PET/CT) procedure. The retrospective study involves 207 patients with confirmed malignancies who underwent PET/CT. Effective dose (E) from PET was estimated based on injected activity and dose coefficient as per International Commission on Radiation Protection (ICRP) 128. Estimation of E from CT was done utilizing the dose length product (DLP) method and conversion factors as per ICRP 102. There was a significant statistical difference observed in E between different PET/CT protocols (P < .001). E of PET in the whole body (WB) was found to be 4.9 ± 0.9 mSv, whereas mean volume computed tomography dose indexvol, DLP, and E of CT in WB were 7.0 ± 0.2 mGy, 674.3 ± 80.7 mGy.cm, and 10.1 ± 1.2 mSv, respectively. No linear correlation was seen between the size-specific dose estimate and E of CT (r = −0.003; P = .978). The total mean E in WB PET/CT was 17.0 ± 1.7 mSv. CT dose was contributing more than PET dose in all protocols except brain PET/CT. Optimization strategies can be evaluated only if monitored periodically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyRadiation DosageRadiopharmaceuticalsHumansMaleFemaleRetrospective StudiesMiddle AgedAdultAgedNeoplasmsYoung AdultAged, 80 and overWhole Body Imaging

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, Advanced Centre for Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai 410210, India.
  • Homi Bhabha National Institute, Mumbai 400094, India.
  • Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Tata Memorial Centre, Dr Ernest Borges Rd, Parel, Mumbai, Maharashtra 400012, India.

ORCID-Profile: Pooja Dwivedi

Zitieren

APA

Dwivedi, P., Kumar Jha, A., Mithun, S., Sawant, V., Vajarkar, V., Chauhan, M., Choudhury, S., & Rangarajan, V. (2024). Dose estimation in patients from different protocols of 18F-FDG PET/CT studies and analysis of optimization strategies. Radiation Protection Dosimetry. https://doi.org/10.1093/rpd/ncae179

Vancouver

Dwivedi P, Kumar Jha A, Mithun S, Sawant V, Vajarkar V, Chauhan M, et al. Dose estimation in patients from different protocols of 18F-FDG PET/CT studies and analysis of optimization strategies. Radiation Protection Dosimetry. 2024. doi:10.1093/rpd/ncae179

BibTeX
@article{Dwivedi2024,
  author = {Dwivedi, Pooja and Kumar Jha, Ashish and Mithun, Sneha and Sawant, Viraj and Vajarkar, Vishal and Chauhan, Manoj and Choudhury, Sayak and Rangarajan, Venkatesh},
  title = {Dose estimation in patients from different protocols of 18F-FDG PET/CT studies and analysis of optimization strategies},
  journal = {Radiation Protection Dosimetry},
  year = {2024},
  doi = {10.1093/rpd/ncae179}
}
Kostenlos starten →